No black box warning on record for Tembexa

As of the latest FDA labeling reviewed, Tembexa (BRINCIDOFOVIR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tembexa medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Elevations in Hepatic Transaminases and Bilirubin: May cause increases in serum transaminases (ALT or AST) and serum bilirubin. Monitor liver laboratory parameters before and during treatment. ( 5.2 ) • Diarrhea and Other Gastrointestinal Adverse Events: Diarrhea and additional gastrointestinal adverse events including nausea, vomiting, and abdominal pain may occur. Mo

No black box warning on record for Tembexa

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Elevations in Hepatic Transaminases and Bilirubin: May cause increases in serum transaminases (ALT or AST) and serum bilirubin. Monitor liver laboratory parameters before and during treatment. ( 5.2 ) • Diarrhea and Other Gastrointestinal Adverse Events: Diarrhea and additional gastrointestinal adverse events including nausea, vomiting, and abdominal pain may occur. Mo

Tembexa Black Box Warning

No black box warning on record for Tembexa

Other warnings & precautions

Tembexa Black Box Warning

No black box warning on record for Tembexa

Other warnings & precautions